Loss Contingency, Claims Finalized, Number Of States

No definition available.

Name:	indv_LossContingencyClaimsFinalizedNumberOfStates
Namespace Prefix:	indv_
Data Type:	xbrli:integerItemType
Balance Type:	na
Period Type:	instant

- Definition

Loss Contingency, Claims Finalized, Number Of Subdivisions

+ References

No definition available.

+ Details

Name:	indv_LossContingencyClaimsFinalizedNumberOfSubdivisions
Namespace Prefix:	indv_
Data Type:	xbrli:integerItemType
Balance Type:	na
Period Type:	instant

- Definition

Loss Contingency, Expected Trial Period

+ References

No definition available.

+ Details

Name:	indv_LossContingencyExpectedTrialPeriod
Namespace Prefix:	indv_
Data Type:	xbrli:durationItemType
Balance Type:	na
Period Type:	duration

- Definition

Loss Contingency, Tolled Claims, Number Of Individuals

+ References

No definition available.

+ Details

Name:	indv_LossContingencyTolledClaimsNumberOfIndividuals
Namespace Prefix:	indv_
Data Type:	xbrli:integerItemType
Balance Type:	na
Period Type:	duration

- Definition

Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.

+ References

Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
-Topic 450
-SubTopic 20
-Name Accounting Standards Codification
-Section 50
-Paragraph 9
-Subparagraph (a)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147483076/450-20-50-9

Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef
-Topic 450
-SubTopic 20
-Name Accounting Standards Codification
-Section 50
-Paragraph 4
-Subparagraph (a)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147483076/450-20-50-4

Reference 3: http://www.xbrl.org/2003/role/disclosureRef
-Topic 405
-SubTopic 30
-Name Accounting Standards Codification
-Section 50
-Paragraph 1
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482645/405-30-50-1

Reference 4: http://www.xbrl.org/2003/role/disclosureRef
-Topic 944
-SubTopic 40
-Name Accounting Standards Codification
-Section S99
-Paragraph 1
-Subparagraph (SAB Topic 5.W.Q2)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147479583/944-40-S99-1

Reference 5: http://www.xbrl.org/2003/role/disclosureRef
-Topic 275
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 9
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482861/275-10-50-9

Reference 6: http://www.xbrl.org/2003/role/disclosureRef
-Topic 720
-SubTopic 20
-Name Accounting Standards Codification
-Section 50
-Paragraph 1
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147483359/720-20-50-1

Reference 7: http://www.xbrl.org/2003/role/exampleRef
-Topic 460
-SubTopic 10
-Name Accounting Standards Codification
-Section 55
-Paragraph 27
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482395/460-10-55-27

Reference 8: http://www.xbrl.org/2003/role/disclosureRef
-Topic 450
-SubTopic 20
-Name Accounting Standards Codification
-Section 50
-Paragraph 9
-Subparagraph (b)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147483076/450-20-50-9

Reference 9: http://www.xbrl.org/2003/role/disclosureRef
-Topic 450
-SubTopic 20
-Name Accounting Standards Codification
-Section 50
-Paragraph 4
-Subparagraph (b)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147483076/450-20-50-4

Reference 10: http://www.xbrl.org/2003/role/disclosureRef
-Topic 460
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 3
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482425/460-10-50-3

Reference 11: http://www.xbrl.org/2003/role/disclosureRef
-Topic 450
-SubTopic 20
-Name Accounting Standards Codification
-Section 50
-Paragraph 1
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147483076/450-20-50-1

+ Details

Name:	us-gaap_LossContingenciesLineItems
Namespace Prefix:	us-gaap_
Data Type:	xbrli:stringItemType
Balance Type:	na
Period Type:	duration

- Definition

Number of claims dismissed.

+ References

+ Details

Name:	us-gaap_LossContingencyClaimsDismissedNumber
Namespace Prefix:	us-gaap_
Data Type:	xbrli:integerItemType
Balance Type:	na
Period Type:	duration

- Definition

The total number of new claims filed pertaining to a loss contingency during the period.

+ References

+ Details

Name:	us-gaap_LossContingencyNewClaimsFiledNumber
Namespace Prefix:	us-gaap_
Data Type:	xbrli:integerItemType
Balance Type:	na
Period Type:	duration

- Definition

Number of plaintiffs that have filed claims pertaining to a loss contingency.

+ References

+ Details

Name:	us-gaap_LossContingencyNumberOfPlaintiffs
Namespace Prefix:	us-gaap_
Data Type:	xbrli:integerItemType
Balance Type:	na
Period Type:	duration

- Definition

Number of pending claims pertaining to a loss contingency.

+ References

+ Details

Name:	us-gaap_LossContingencyPendingClaimsNumber
Namespace Prefix:	us-gaap_
Data Type:	xbrli:integerItemType
Balance Type:	na
Period Type:	instant

- Details

Name:	srt_LitigationCaseAxis=indv_DentalAllegationsMDLMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

- Details

Name:	us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

- Details

Name:	srt_LitigationCaseAxis=indv_DentalAllegationsMDLScheduleAMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

- Details

Name:	srt_LitigationCaseAxis=indv_DentalAllegationsStateCourtMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

- Details

Name:	srt_LitigationCaseAxis=indv_CivilOpioidLitigationMDLStateAndSubdivisionMSAMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

- Details

Name:	srt_LitigationCaseAxis=indv_CivilOpioidLitigationMDLNeonatalAbstinenceSyndromeMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

- Details

Name:	srt_LitigationCaseAxis=indv_CivilOpioidLitigationMDLThirdPartyPayorMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

- Details

Name:	srt_LitigationCaseAxis=indv_CivilOpioidLitigationMDLCharitableOrganizationMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

- Details

Name:	srt_LitigationCaseAxis=indv_CivilOpioidLitigationMDLIndividualPlaintiffsMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

- Details

Name:	srt_LitigationCaseAxis=indv_U.K.ShareholderClaimsFirstTrialMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

- Details

Name:	srt_StatementScenarioAxis=srt_ScenarioForecastMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

Commitments and Contingencies (Details) subdivision in Thousands			3 Months Ended	6 Months Ended
	Jul. 24, 2026 plaintiff claim	Jun. 14, 2024 claim plaintiff	Dec. 31, 2028	Jun. 30, 2026 claim individual	Jan. 31, 2026 subdivision state
Dental Allegations, MDL \| Subsequent Event
Loss Contingencies [Line Items]
Number of pending claims	1,967
Number of plaintiffs \| plaintiff	26,307
Dental Allegations, MDL Schedule A
Loss Contingencies [Line Items]
Number of plaintiffs \| plaintiff		10,000
Number of new claims filed		1
Dental Allegations, MDL Schedule A \| Subsequent Event
Loss Contingencies [Line Items]
Number of plaintiffs \| plaintiff	4,854
Dental Allegations, State Court
Loss Contingencies [Line Items]
Number of new claims filed				1
Number of individuals with tolled claims (more than) \| individual				950
Civil Opioid Litigation, MDL, State and Subdivision MSA
Loss Contingencies [Line Items]
Number of states where claims were finalized \| state					49
Number of subdivisions where claims were finalized \| subdivision					10
Civil Opioid Litigation, MDL, Neonatal Abstinence Syndrome
Loss Contingencies [Line Items]
Number of pending claims				26
Number of claims dismissed (over)				100
Civil Opioid Litigation, MDL, Third Party Payor
Loss Contingencies [Line Items]
Number of pending claims				1
Civil Opioid Litigation, MDL, Charitable Organization
Loss Contingencies [Line Items]
Number of pending claims				1
Civil Opioid Litigation, MDL, Individual Plaintiffs
Loss Contingencies [Line Items]
Number of pending claims				7
U.K. Shareholder Claims, First Trial \| Subsequent Event \| Forecast
Loss Contingencies [Line Items]
Expected trial period			56 days